
Serum Institute of India (SII) CEO Adar Poonawalla took to Twitter to confirm that they have applied for emergency use authorisation for the India-made COVID-19 vaccine, Covishield. "This will save countless lives...I thank the Government of India and PM Narendra Modi ji for their invaluable support," he added. SII is the first Indian company and second overall to seek approval.